TSE Advisory Committee October 25, 2001 Center for Food Safety and Applied Nutrition Food and Drug Administration Washington, DC 20204 Topic 3.

Slides:

Advertisements

Similar presentations

Federal Food, Drug, and Cosmetic Act 1938, 1954, 1958 (FFDCA)

Advertisements

The United States Federal Food, Drug, and Cosmetic Act (FFDCA)

Bovine Spongiform Encephalopathy (BSE) in Canada Pedro Piccardo, MD Division of Emerging and Transfusion-Transmitted Diseases Office of Blood Research.

Regulating Food Additives. Food and Drug Administration (FDA) 1938 – Federal Food, Drug, and Cosmetics Act Authority over food and food ingredients Defined.

Analysis to Inform Decisions: Evaluating BSE Joshua Cohen and George Gray Harvard Center for Risk Analysis Harvard School of Public Health.

Introduction Youth Pork Quality Assurance Plus TM A Program for Youth Pork Producers.

Mad Cow Disease 袁聖甯黃竹瑄鄧雯心. What is Mad Cow Disease ? A kind of transmissible spongiform encephalopathies (TSE) Occurs in many mammals, including human.

History of FDA and Related Regulatory Agencies

Government Agencies HUM-FNW-3 Unit 4. USDA United States Department of Agriculture Mission Statement We provide leadership on food, agriculture, natural.

Introduction to Regulation

Food Safety Program 4-H Veterinary Science Extension Veterinary Medicine Texas AgriLife Extension Service College of Veterinary Medicine and Biomedical.

Mad Cow Disease. Effects of Mad Cow disease Mad cow disease, or bovine spongiform encephalopathy (BSE), is a fatal brain disorder that occurs in cattle.

Lesson 2: How Does Your Garden Grow? Meat and Milk Production.

Ohio Nano-Summit March 3, 2005 REGULATORY CONSIDERATIONS FOR NANOTECHNOLOGY IN PUBLIC HEALTH FOOD AND DRUG ADMINISTRATION Norris E. Alderson, Ph.D. Associate.

Canadian and U.S. BSE Risk Steven Anderson, Ph.D, MPP Office of Biostatistics & Epidemiology Center for Biologics Evaluation & Research U.S. Food & Drug.

-Drafted in Amendment Years were in 1954 and National law in United States.

FDA Recalls Risk Communication Advisory Committee David K. Elder Director, Office of Enforcement.

Nutritional/dietary Supplements Chris Sauro HW 499 Professor Davis 7/27/14.

AFLATOXIN REGULATORY ISSUES Garnett E. Wood, Ph.D. Food and Drug Administration Center for Food Safety and Applied Nutrition Center for Food Safety and.

Dietary Supplements Bradford W. Williams Special Assistant Division of Dietary Supplement Programs ONPLDS, CFSAN, FDA.

Food Safety and Inspection Service U. S. Department of Agriculture

Introduction to US Health Care

Providing Safe Food Chapter 1.

Tanzania Aflatoxin Workshop December 3 and 4, 2012 Collaboration across Ministries of Health, Agriculture and Livestock to enhance dietary diversity and.

Implementing Pre- Harvest Food Safety-- The U.S. Approach By Thomas J. Billy, Administrator Food Safety and Inspection Service U.S. Department of Agriculture.

Images shutterstock.com Food Science: An Old but New Subject Chapter 1 Remind Ms J to clock in.

Food/Drug Inspector By: Weston and Cody. Training/Educaton Bachelor of Science in Food Science A 4-year bachelor's degree program in food science can.

Federal Food, Drug, and Cosmetic Act 1938, 1954, 1958 (FFDCA) Katie Buhai Period 3.

REGULATORY CHALLENGES FOR NANOMATERIALS IN PUBLIC HEALTH Driving Faster Than Our Nano-Headlights AAAS Annual Meeting February 13, 2009 Norris E. Alderson,

Regulation and Labeling Food Technology Ch 26. Regulation and Labeling The Food and Drug Administration (FDA) and the United States Dept of Agriculture.

NS 440 LEGAL AND REGULATORY ENVIRONMENT IN FOOD PRODUCTION SPRING YOUNTS DAHL, MS PHD INSTRUCTOR Unit 5: Policy Considerations in Food Regulation.

Pathogen Reduction Dialogue Panel 4 May 7, 2002 On Farm Food Safety A Process of Intervention Martin Firth Manager, Policy and Strategies Canadian Food.

Center for Food Safety and Applied Nutrition (CFSAN) Golriz Khadem And Ryan Leitz.

Bovine-derived Products Used in the Manufacture and Formulation of Vaccines and Allergenic Products: Minimizing TSE Risks William M. Egan, Ph.D. Acting.

Food Safety …From Farm to Table By: Allison Weis

SAFEGUARDING THE FOOD SUPPLY HOW DO WE PROTECT THE FOOD SUPPLY FOR AN ENTIRE NATION?

Food and Drug Administration & Outbreaks

S.H.I.E.L.D Strategic, Hazard Intervention, Espionage Logistics Directorate.

FDA TSE Advisory Committee Meeting October 25, 2001 Topic 2 Amino Acid Production and the Associated Theoretical Risk of BSE Transmission from their Use.

HACCP Prepared By: Mrs. F. Malcolm-Hanson Date: 29 th November,2013 Group: 2 nd Year (Nutrition) Week: 12.

HEALTH AGENCIES WORLD WIDE NATIONAL STATE & LOCAL.

OHIO STATE UNIVERSITY EXTENSION go.osu.edu/AQCA Youth Food Animal Quality Assurance Curriculum Guide Food Safety and Government Relations.

Mission, Organization, and Operations Presentation by Gray Etheredge and Cathy Chang January 20, 2004.

FDA job description  Regulates about 25% of all consumer purchases  Mission summary: protect and advance public health  Products: food, cosmetics, drugs,

Should the UW continue to be allowed to use primates for their research? Name Class hour:

David M. Asher, MD Division of Emerging & Transfusion-Transmitted Diseases Office of Blood Research & Review Center for Biologics Evaluation & Research.

Food Laws and Regulations Unit 3 Seminar NS 440. Food Laws and Regulations  Why are they important, necessary?

FDA Risk Communication Nancy M. Ostrove, PhD Senior Advisor for Risk Communication Risk Communication Advisory Committee February 28, 2008.

2 Objectives 1.To identify and distinguish among government agencies and their role in food safety 2.To analyze and apply the laws set by government agencies.

SB/E 3.03 SB/E 3.03 Category 3 Category 4 Category 5 1pt 1 pt 1 pt 1pt

AFLATOXIN REGULATORY ISSUES

Human Services Delivery Systems and Organizations

Human Services Delivery Systems and Organizations

By Rebecca Moulder GRIT 700

Food Safety and Government Relations

Government Regulations

Food and drug administration

Government Regulations to Control Diseases

What we all need to know about the powers that be!

Human Services Delivery Systems and Organizations

Frequently Asked Questions About BSE

(National) Federal Food, Drug, and Cosmetic Act (FFDCA) 1938 (Amended 1954 and 1958) Jenny Tumay Period 3.

CENTER FOR BIOLOGICS EVALUATION AND RESEARCH

Government Regulations for Disease Prevention

Federal Food, Drug, and Cosmetic Act By: Kaytlynn Martin Period 6

Professional Organizations

Federal Food, Drug, and Cosmetic Act 1938, 1954, 1958

Patient Involvement in the Development and Safe Use of

Final Rule on Foreign Supplier Verification Programs

Regulation of Food Properties

Presentation transcript:

TSE Advisory Committee October 25, 2001 Center for Food Safety and Applied Nutrition Food and Drug Administration Washington, DC Topic 3

l Bovine Brain, Spinal Cord, and Other Neurological Tissue in Foods, Drugs, and Cosmetics for Human Use

Purpose l To determine the benefit, if any, of restricting the use of bovine neurological tissues and products derived from these tissues in foods, drugs, and cosmetics for human use

Background l Neurological tissues are the most highly infective tissues in BSE-infected cattle. l These tissues may be used as human food and may be used in a variety of FDA- regulated products. l FDA is not aware of any practical analytical tests for detecting the BSE agent in ingredients or products.

FDA Authorities l Public Health Service Act: Make and enforce regulations to prevent introduction, transmission, or spread of a communicable disease. l Federal Food, Drug, and Cosmetic Act: Ensure the safety of cosmetics, food (including dietary supplements) and feed, drugs (including animal drugs), vaccines, biologics, blood products, and medical devices.

USDA Regulates: l Most meat (beef, pork, lamb, horse, goat) l Poultry l Egg products (liquid, frozen, and dried)

Question 1

Question 2 l Is there a consistent and appreciable difference in infectivity of various sections/areas of bovine brain? If so, what are the differences in relative degrees of infectivity of these areas?

Question 3 l Are there other bovine neurological tissues that, if used in consumer products (such as foods, dietary supplements, cosmetics, and certain non-application drugs), could also pose a significant health hazard? If so, what are the differences in relative degrees of infectivity of these tissues?

Question 4 l What physical, chemical, or biological factors of tissues and/or processes should FDA consider in reviewing procedures that may have the ability to reduce infectivity of bovine neurological tissues and products containing bovine neurological tissues?

Question 5 l What tests are available to ascertain changes in infectivity in products containing bovine neurological tissues as a result of processing?

Question 6 l What level of reduction in infectivity is necessary to consider products containing bovine neurological tissues non-infective or "safe" for human use?